DrugRisk Update: Canada Begins Yaz Class Action As Cases Settle in U.S.

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

Dallas, TX (PRWEB) February 12, 2013

The prescription drug resource center DrugRisk.com is alerting womentaking the birth control drugs Yaz or Yasmin of new information added to the site which shows patients in Canada have proposed the joining of injury claims into a Yaz class action. Meanwhile, Bayer continues to settle claims over blood clots filed in the United States.

“The goal of DrugRisk is to improve patient safety through education. This includes the latest warnings, recalls and legal action related to popular prescription drugs and medical devices. Patients who are informed can better discuss their options with their doctor and decide if they need the advice of a lawyer,” explains DrugRisk representative Ryan Mayer.

The resource center had previously added warnings about birth control drugs like Yaz and Yasmin from experts such as the American College of Obstetricians and Gynecologists, who stated that birth control pills containing drospirenone may present a higher risk of blood clots.*

DrugRisk.com also contains information about the thousands of Yaz lawsuits which have been filed by patients in the U.S. over blood clots, which have been consolidated in a special federal Multi-District Litigation court in Illinois.**

In new information added to the site, Bayer spokesperson Marija Mandic admits that the company also faces as many as 13 proposed Yazclass action claims in Canada.***

According to Bayer’s most recent financial statements uncovered by DrugRisk, the company has set aside as much as $750 million for Yaz settlements in the United States, resolving as many as 3,500 cases so far at an average of nearly $214,000 per case.****

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

However, the Drug Risk Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Chicago Tribune October 24, 2012, “Newer Pill has low blood clot risk: ob-gyn group”
**Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).
***cbc.ca/hamilton/news/story/2013/01/28/hamilton-yasmin-lawsuit.html
****Bayer Interim Financial Statement, Legal Notes and Business Development, September 30, 2012


Contact